CIM
ESPR

CIM Investment Management’s Esperion Therapeutics ESPR Stock Holding History

CIM Investment Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,716
Closed -$287K – 292
2020
Q3 		$287K Buy
7,716
+112
+1% +$4.44K 0.11% 174
2020
Q2 		$390K Buy
+7,604
New +$318K 0.16% 127
2019
Q4 		– Sell
-6,486
Closed -$238K – 253
2019
Q3 		$238K Hold
6,486
– – 0.09% 282
2019
Q2 		$302K Sell
6,486
-658
-9% -$30.9K 0.11% 233
2019
Q1 		$287K Sell
7,144
-61
-0.8% -$2.74K 0.11% 247
2018
Q4 		$331K Hold
7,205
– – 0.14% 187
2018
Q3 		$320K Hold
7,205
– – 0.11% 257
2018
Q2 		$282K Hold
7,205
– – 0.1% 288
2018
Q1 		$521K Buy
7,205
+2,911
+68% +$214K 0.18% 158
2017
Q4 		$283K Sell
4,294
-87
-2% -$4.68K 0.1% 270
2017
Q3 		$220K Sell
4,381
-4,387
-50% -$212K 0.08% 300
2017
Q2 		$406K Sell
8,768
-282
-3% -$10.4K 0.14% 201
2017
Q1 		$320K Sell
9,050
-8,900
-50% -$204K 0.11% 252
2016
Q4 		$225K Hold
17,950
– – 0.08% 308
2016
Q3 		$249K Buy
17,950
+680
+4% +$7.71K 0.1% 293
2016
Q2 		$171K Buy
17,270
+1,720
+11% +$28.5K 0.07% 282
2016
Q1 		$263K Buy
+15,550
New +$250K 0.11% 217
2015
Q3 		– Sell
-2,669
Closed -$218K – 260
2015
Q2 		$218K Buy
+2,669
New +$261K 0.1% 227

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

CIM Investment Management's ESPR Position: Q4 2020 in Review

CIM Investment Management sold out of Esperion Therapeutics (ESPR) in Q4 2020, closing a stake of 7,716 shares — an estimated $287K sold.

CIM Investment Management first reported a position in ESPR in Q2 2015 and held it in 18 quarters. The position peaked at $521K in Q1 2018. 157 funds tracked by Wall St. Rank hold ESPR as of Q4 2020.

  • CIM Investment Management reported no remaining Esperion Therapeutics position as of Q4 2020 after selling out during the quarter.
  • CIM Investment Management sold 7,716 Esperion Therapeutics shares in Q4 2020, an estimated $287K.
  • CIM Investment Management first reported a position in Esperion Therapeutics in Q2 2015 and held it in 18 quarters.
  • CIM Investment Management's Esperion Therapeutics position peaked at $521K in Q1 2018.
  • 157 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2020.

Based on CIM Investment Management's 13F filing for Q4 2020, filed 17 Feb 2021.